Nuvation Bio Inc. (NUVB)
2.46
-0.04 (-1.60%)
At close: Jan 28, 2025, 1:54 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -75.80M | -104.20M | -86.85M | -41.66M | -33.55M | -992.00K |
| Depreciation & Amortization | 222.00K | 199.00K | 184.00K | 103.00K | 13.00K | n/a |
| Stock-Based Compensation | 19.51M | 16.29M | 9.27M | 2.20M | n/a | n/a |
| Other Working Capital | 470.00K | -1.66M | 2.93M | 2.08M | -460.00K | 265.33K |
| Other Non-Cash Items | -12.47M | -4.95M | 3.97M | 715.00K | 9.57M | 110.67K |
| Deferred Income Tax | n/a | n/a | 442.00K | n/a | n/a | n/a |
| Change in Working Capital | 540.00K | -3.45M | 4.79M | 2.11M | -460.00K | 265.33K |
| Operating Cash Flow | -68.00M | -96.11M | -68.19M | -36.53M | -24.43M | -616.00K |
| Capital Expenditures | -69.00K | -370.00K | -282.00K | -145.00K | -659.00K | n/a |
| Acquisitions | n/a | 13.00K | 454.67M | -2.51M | n/a | n/a |
| Purchase of Investments | -703.37M | -520.31M | -609.30M | -143.29M | n/a | n/a |
| Sales Maturities Of Investments | 712.35M | 584.12M | 154.91M | 73.11M | n/a | n/a |
| Other Investing Acitivies | 14.00K | 63.83K | -454.67M | 2.51M | -115.20M | n/a |
| Investing Cash Flow | 8.92M | 63.46M | -454.67M | -70.32M | -115.86M | n/a |
| Debt Repayment | n/a | n/a | n/a | n/a | 14.99M | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 628.00K | 1.33M | 625.53M | -2.52M | 128.63M | 800.00K |
| Financial Cash Flow | 628.00K | 1.33M | 625.53M | 133.13M | 143.62M | 800.00K |
| Net Cash Flow | -58.45M | -31.32M | 102.67M | 26.29M | 3.33M | 184.00K |
| Free Cash Flow | -68.07M | -96.48M | -68.47M | -36.67M | -25.09M | -616.00K |